ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation (ADPT)

4.20
0.04
(0.96%)
Closed July 23 4:00PM
4.20
0.00
( 0.00% )
Pre Market: 7:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
4.20
Bid
3.90
Ask
4.37
Volume
-
0.00 Day's Range 0.00
2.28 52 Week Range 8.51
Market Cap
Previous Close
4.20
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,450,151
Shares Outstanding
147,368,324
Dividend Yield
-
PE Ratio
-2.75
Earnings Per Share (EPS)
-1.53
Revenue
170.28M
Net Profit
-225.25M

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for... Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Olympia, Washington, USA
Founded
1970
Adaptive Biotechnologies Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADPT. The last closing price for Adaptive Biotechnologies was $4.20. Over the last year, Adaptive Biotechnologies shares have traded in a share price range of $ 2.28 to $ 8.51.

Adaptive Biotechnologies currently has 147,368,324 shares outstanding. The market capitalization of Adaptive Biotechnologies is $618.95 million. Adaptive Biotechnologies has a price to earnings ratio (PE ratio) of -2.75.

ADPT Latest News

Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024

SEATTLE, July 11, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

SEATTLE, May 31, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...

Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

SEATTLE, May 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.23-5.191873589164.434.653.9459118814.20445823CS
40.8525.37313432843.354.653.2614406253.81995914CS
121.5759.69581749052.634.652.5614501513.56873716CS
26-0.27-6.040268456384.474.652.2815663913.39785594CS
52-3.88-48.01980198028.088.512.2815029334.23767058CS
156-34.29-89.088074824638.49402.2812164789.145571CS
260-36.1-89.578163771740.371.252.28108606619.30521774CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DRMADermata Therapeutics Inc
$ 2.84
(118.46%)
10.53M
HOTHHoth Therapeutics Inc
$ 1.80
(85.19%)
7.66M
NUZENuZee Inc
$ 1.73
(67.96%)
2.32M
RGCRegencell Bioscience Holdings Ltd
$ 21.91
(46.46%)
378.44k
BBLGBone Biologics Corporation
$ 1.74
(39.20%)
869.25k
VWEVintage Wine Estates Inc
$ 0.0766
(-31.55%)
786.58k
CONNConns Inc
$ 0.3629
(-28.42%)
116.85k
VSTMVerastem Inc
$ 2.67
(-25.63%)
59.8k
TCBPTC BioPharm Holdings PLC
$ 0.60
(-25.00%)
502
ATPCAgape ATP Corporation
$ 0.1673
(-22.19%)
477.22k
ALLRAllarity Therapeutics Inc
$ 0.223
(33.93%)
27.54M
DRMADermata Therapeutics Inc
$ 2.84
(118.46%)
10.53M
SLNASelina Hospitality PLC
$ 0.027
(3.85%)
9.49M
HOTHHoth Therapeutics Inc
$ 1.80
(85.19%)
7.66M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 11.38
(-16.93%)
3.54M

Discussion

View Full Feed
Hi_Lo Hi_Lo 5 minutes ago
Shell companies or companies that were once a shell company must register with the SEC.

CIVX is (or once was) a shell company.

https://investorshub.advfn.com/uimage/uploads/2024/7/17/ikckiScreenshot_20240717_163311_Chrome.jpg

https://www.securitieslawyer1
CIVX
TRAPPER JIM TRAPPER JIM 6 minutes ago
I can’t wait to move into the new house. I’m so excited about it
snow snow 9 minutes ago
RD As a principle I think you should be paid even in some sort of supporting role. But if you command a net worth of tens of millions of dollars it may be better for you not to be paid since it would give you more freedom to dispose of your time. Having a lot invested in these businesses would give
ITUP
LVerstee LVerstee 9 minutes ago
Today is Wednesday. Today!
ITUP
TJ24 TJ24 9 minutes ago
How do we know that, if RDGL does get FDA approval, RDGL will not simply go private and cheat retail investors?

The company called RSP* received Dept. of Defense funding, and then proceeded to deliberately miss a filing deadline, tank the stock price (pressuring some retail investors
RDGL RSP
PonkenPlonken PonkenPlonken 9 minutes ago
wants to do that super silly thing?
RGC
Awl416 Awl416 10 minutes ago
Yikes
BBLG
pickthemright pickthemright 12 minutes ago
What’s with all the volume ?
ALPP
Runlebbyrun Runlebbyrun 13 minutes ago
Looking at all the shorters reactions, they are starting to panic. (and they should) Won't be long now Longs. Hold on and witness this once in a lifetime opportunity to unfold.....
LWLG
Wayne R Wayne R 15 minutes ago
Sounds like the book flashback, might be a movie too
HNRC
uranium-pinto-beans uranium-pinto-beans 16 minutes ago
Spotify price target raised to $400 from $370 at Canaccord
Canaccord raised the firm's price target on Spotify to $400 from $370 and keeps a Buy rating on the shares. The firm said they reported strong Q2 results, with Premium subscribers and total revenue in line with expectations, while gro
PennyMillions852 PennyMillions852 16 minutes ago
KitCRAP maybe you should look in the dictionary as you are the poster child of IDIOTS!!!
IGPK
Stanny belgium Stanny belgium 17 minutes ago
@ WooptdooU: Can you raise the level op your posts a bit. The last 5 suggest a previously unregistered low IQ !
LWLG
DKLN DKLN 17 minutes ago
Do you ever get discouraged that usually only one other person (another pusher) responds "good morning"? It's one of the many hilarious things about the MCIC Board.

MCIC - To Uranus
MCIC
Awl416 Awl416 17 minutes ago
Oh stop it
TIRX
manuel06 manuel06 19 minutes ago
https://clients2.weblink.com.au/clients/pancon/article.asp?asx=PCL&view=61217002
SEUSF
art2426 art2426 20 minutes ago
>>>Her favorite response? "We'll release a PR when it's appropriate."
BIEL
work-n-hard work-n-hard 21 minutes ago
SGMO: Moving up. Pfizer https://www.nasdaq.com/press-release/sangamo-therapeutics-reports-pfizers-announcement-positive-topline-results-phase-3
SGMO
manuel06 manuel06 21 minutes ago
https://clients2.weblink.com.au/clients/pancon/article.asp?asx=PCL&view=61217002
PCOGF
jackson73 jackson73 22 minutes ago
HOTH 1.90 broke resistance
HOTH
DJ Ponder DJ Ponder 22 minutes ago
Yep, the little B for sure!
Chihuahua!

BWAHAHAHAHAHAHAHAHAHA !
ATMH
PonkenPlonken PonkenPlonken 23 minutes ago
HOTH LTS is a great partner, they mustve seen/liked something-- yet be careful, no biobucks
HOTH
Bull_Dolphin Bull_Dolphin 23 minutes ago
Even worse than that, "We're incompetent, so you need to give up your freedom."
Jack_Bolander Jack_Bolander 23 minutes ago
WTM - I am equally interested in your thoughts.

$2.50 ! That recent capital raise sure was expensive money for PLUG and even more so for PLUG shareholders.

Do you think "Going Concern" language would have cost Shareholders more than the Secondary did ?

PLUG

Your Recent History

Delayed Upgrade Clock